Global Schizophrenia Therapeutics Market: Key vendors - AstraZeneca, Eli Lilly, GlaxoSmithKline

Latest industry research report on: Global Schizophrenia Therapeutics Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts

Schizophrenia is a chronic mental disorder that alters the perception, thinking, and social behavior of an individual. Individuals suffering from this disease face difficulty in distinguishing between imaginary things and reality. Although schizophrenia is not as prevalent as other mental disorders, it affects 7 or 8 individuals out of 1,000 people. Globally, the disease affects 1% of the total population. Schizophrenic patients are usually diagnosed with low levels of dopamine and serotonin. These are major neurotransmitters in the brain and are responsible for transmitting nerve signals from one neuron to another neuron. Deficiency of these neurons in the brain leads to impairment of thinking, perception, and the activity of an individual. At present, the treatment regimen for this disease focuses on relieving symptoms. Thus, antipsychotic drugs are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.

Technavios analysts forecast the global schizophrenia therapeutics market to grow at a CAGR of 1.84% during the period 2017-2021.

Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1267319

Covered in this report
The report covers the present scenario and the growth prospects of the global schizophrenia therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

Technavio's report, Global Schizophrenia Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Have Any Query? Ask Our Expert @https://www.marketresearchreports.biz/sample/enquiryBuy/1267319
Key vendors 

• AstraZeneca
• Eli Lilly
• GlaxoSmithKline
• Johnson & Johnson

Other prominent vendors
Alkermes
Bristol-Myers Squibb

Market driver
Increasing expenditure on prescription drugs
For a full, detailed list, view our report

Market challenge
Technological advances in non-invasive neuromodulation devices
For a full, detailed list, view our report

Market trend
Increase in use of LAI antipsychotic drugs
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?